Mallie Sarkar

Specialties: Gene Therapy, CAR-T , Clinical, Scientific, Regulatory, New Business Development, L,M&A, Medical Device/Biotech, Nutraceuticals Rare disease, Neurological disorders, Muscular diseases, Autoimmune, GI, Kidney, Pulmonary, Infectious diseases, metabolic cardiovascular, preterm infants, neonates to adults Clinical Development, Pre-clinical and Translational Medicine research Gene therapy - AAV; gene silencing, miRNA; CNS- neurodegenerative, neuromuscular disease, autoimmune,pain, depression, etc Other areas- GI- pancrease, liver; cardiovacular, metabolic/endocrine; nurition; infectious diseases, Early development, discovery, Phase 1-IV Extensive scientific and clinical and pre-clinical research experience including in gene therapy, direct patient care experience, and a very broad cross-functional experience, therapeutic knowledge includes academic and industry- startups and Fortune 500 companies. MD&D, Pharmaceutical R&D product development knowledge with advanced understanding of other functions; including, but not limited to Research, Toxicology, Pharmacology, Clinical, Manufacturing and Operations, Regulatory, and Medical Affair. Critical Thinker. Recognized for superior problem-solving, relationship building, hands-on aptitude/attitude, risk managment and strategic planning skills.